Kenji Ishida

425 total citations
20 papers, 364 citations indexed

About

Kenji Ishida is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Kenji Ishida has authored 20 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in Kenji Ishida's work include Microbial Natural Products and Biosynthesis (4 papers), Escherichia coli research studies (4 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Kenji Ishida is often cited by papers focused on Microbial Natural Products and Biosynthesis (4 papers), Escherichia coli research studies (4 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Kenji Ishida collaborates with scholars based in United States, South Korea and Japan. Kenji Ishida's co-authors include L. B. Guze, G. M. Kalmanson, Timothy A. Miller, Kwangkyoung Liou, Phyllis A. Guze, Hei Chan Lee, Jae Kyung Sohng, Jerome S. Wollman, Andrew E. Turk and John Z. Montgomerie and has published in prestigious journals such as Analytical Chemistry, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Kenji Ishida

20 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenji Ishida United States 11 148 90 70 67 62 20 364
G Banck Sweden 11 109 0.7× 63 0.7× 76 1.1× 9 0.1× 65 1.0× 18 442
Michelle J. Bauer Australia 12 166 1.1× 71 0.8× 30 0.4× 70 1.0× 108 1.7× 37 451
Jennifer M. Colquhoun United States 12 252 1.7× 49 0.5× 30 0.4× 38 0.6× 40 0.6× 30 460
A. F. Lokerse Netherlands 8 153 1.0× 36 0.4× 44 0.6× 24 0.4× 65 1.0× 9 372
Atieh Yaghoubi Iran 12 172 1.2× 129 1.4× 24 0.3× 91 1.4× 39 0.6× 33 489
Allison M. Murawski United States 7 130 0.9× 98 1.1× 22 0.3× 43 0.6× 126 2.0× 9 463
Jonathan B. Mandell United States 11 142 1.0× 71 0.8× 12 0.2× 27 0.4× 27 0.4× 27 374
Quanming Zou China 12 194 1.3× 68 0.8× 23 0.3× 28 0.4× 144 2.3× 37 470
Leslie Ecker Ferreira Brazil 9 105 0.7× 68 0.8× 21 0.3× 18 0.3× 125 2.0× 15 282
Alec D. Wilkinson United States 5 149 1.0× 97 1.1× 19 0.3× 25 0.4× 20 0.3× 7 318

Countries citing papers authored by Kenji Ishida

Since Specialization
Citations

This map shows the geographic impact of Kenji Ishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Ishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Ishida more than expected).

Fields of papers citing papers by Kenji Ishida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Ishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Ishida. The network helps show where Kenji Ishida may publish in the future.

Co-authorship network of co-authors of Kenji Ishida

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Ishida. A scholar is included among the top collaborators of Kenji Ishida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Ishida. Kenji Ishida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ishida, Kenji, et al.. (2022). A Novel Propidium Monoazide-Based PCR Assay Can Measure Viable Uropathogenic E. coli In Vitro and In Vivo. Frontiers in Cellular and Infection Microbiology. 12. 794323–794323. 19 indexed citations
2.
Inagaki, Yuji, et al.. (2016). Characterization of strain srt308; a new heterotrophic flagellate basal to Euglenozoa. Protistology. 10(2). 1 indexed citations
3.
4.
Ishida, Kenji, et al.. (2006). Degradation of Clavulanic Acid During the Cultivation of Streptomyces clavuligerus; Instability of Clavulanic Acid by Metabolites and Proteins from the Strain. Journal of Microbiology and Biotechnology. 16(4). 590–596. 7 indexed citations
5.
6.
Ishida, Kenji, et al.. (2006). Enhanced clavulanic acid production inStreptomyces clavuligerus NRRL3585 by overexpression of regulatory genes. Biotechnology and Bioprocess Engineering. 11(2). 116–120. 9 indexed citations
7.
Parajuli, Niranjan, et al.. (2005). Identification and characterization of the afsR homologue regulatory gene from Streptomyces peucetius ATCC 27952. Research in Microbiology. 156(5-6). 707–712. 40 indexed citations
8.
Rudkin, George H., et al.. (1996). Evaluation of a Novel Osteogenic Factor, Bone Cell Stimulating Substance, in a Rabbit Cranial Defect Model. Plastic & Reconstructive Surgery. 98(3). 420–426. 17 indexed citations
9.
Turk, Andrew E., et al.. (1993). Enhanced Healing of Large Cranial Defects by an Osteoinductive Protein in Rabbits. Plastic & Reconstructive Surgery. 92(4). 593–600. 21 indexed citations
10.
Turk, Andrew E., Kenji Ishida, J. Arthur Jensen, Jerome S. Wollman, & Timothy A. Miller. (1993). Enhanced healing of large cranial defects by an osteoinductive protein in rabbits.. PubMed. 92(4). 593–600; discussion 601. 25 indexed citations
11.
Guze, Phyllis A., G. M. Kalmanson, Kenji Ishida, & L. B. Guze. (1987). Strain-Dependent Difference in Susceptibility of Mice to Experimental Ascending Pyelonephritis. The Journal of Infectious Diseases. 156(3). 523–525. 2 indexed citations
12.
Guze, Phyllis A., Benjamin Bonavida, G. M. Kalmanson, et al.. (1985). Strain-Dependent Differences in Susceptibility of Mice to Experimental Pyelonephritis. The Journal of Infectious Diseases. 152(2). 416–419. 4 indexed citations
13.
Ishida, Kenji, et al.. (1984). Treatment of staphylococcal pyelonephritis in rats with N-formimidoyl thienamycin.. PubMed. 3(1). 53–6. 2 indexed citations
14.
Ebright, Jack R., et al.. (1984). Epidemic Shiga Bacillus Dysentery in Central Africa. American Journal of Tropical Medicine and Hygiene. 33(6). 1192–1197. 28 indexed citations
15.
Guze, Lucien B., et al.. (1983). Lack of Significance of Pili in Experimental Ascending Escherichia coli Pyelonephritis. Scandinavian Journal of Infectious Diseases. 15(1). 57–64. 6 indexed citations
16.
Guze, Phyllis A., G. M. Kalmanson, Lawrence R. Freedman, Kenji Ishida, & L. B. Guze. (1983). Antibiotic prophylaxis against streptomycin-resistant and -susceptible Streptococcus faecalis endocarditis in rabbits. Antimicrobial Agents and Chemotherapy. 24(4). 514–517. 6 indexed citations
17.
Ishida, Kenji, Phyllis A. Guze, G. M. Kalmanson, K Albrandt, & L. B. Guze. (1982). Variables in demonstrating methicillin tolerance in Staphylococcus aureus strains. Antimicrobial Agents and Chemotherapy. 21(4). 688–690. 46 indexed citations
18.
Bayer, Arnold S., Anthony W. Chow, Kenji Ishida, Joan O. Morrison, & Lucien B. Guze. (1981). Therapy of Experimental Infective Endocarditis due to Antibiotic-Tolerant <i>Lactobacillus plantarum</i> – Bactericidal Synergy of Penicillin plus Gentamicin. Chemotherapy. 27(6). 444–451. 7 indexed citations
19.
Edwards, John E., et al.. (1979). Experimental hematogenous Candida endophthalmitis: diagnostic approaches. Infection and Immunity. 23(3). 858–862. 10 indexed citations
20.
Edwards, J. E., John Z. Montgomerie, Kenji Ishida, Joan O. Morrison, & L. B. Guze. (1977). Experimental Hematogenous Endophthalmitis Due to Candida: Species Variation in Ocular Pathogenicity. The Journal of Infectious Diseases. 135(2). 294–297. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Banck Breakdown of academic impact, for papers by Michelle J. Bauer Breakdown of academic impact, for papers by Jennifer M. Colquhoun Breakdown of academic impact, for papers by A. F. Lokerse Breakdown of academic impact, for papers by Atieh Yaghoubi Breakdown of academic impact, for papers by Allison M. Murawski Breakdown of academic impact, for papers by Jonathan B. Mandell Breakdown of academic impact, for papers by Quanming Zou Breakdown of academic impact, for papers by Leslie Ecker Ferreira Breakdown of academic impact, for papers by Alec D. Wilkinson
Rankless by CCL
2026